首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 動物用醫藥 > 美國寵物醫療用品、服務市場:2014年、2019年預測
產業/市場分類
製藥 (4816)
肥胖症治療 (44)
非專利藥 (129)
疫苗 (181)
神經疾病 (172)
骨頭疾病治療 (37)
動物用醫藥 (17)
處方藥 (156)
規章 (126)
感染疾病 (346)
精神病 (84)
製藥企業 (524)
糖尿病 (191)
癌症 (909)
藥物開發 (1449)
DDS (182)
OTC 非處方藥 (150)
市場調查報告書

美國寵物醫療用品、服務市場:2014年、2019年預測

Pet Health: Products & Services (US industry forecasts for 2014 & 2019)

出版商 The Freedonia Group
出版日期 2010年08月 商品編碼 125838
內容資訊 英文 285 PAGES
價格
US $ 4800 Hard Copy
US $ 4800 PDF by E-mail (Single User License)
US $ 5400 Hard Copy and PDF by E-mail (Single user license)
US $ 7400 PDF by E-mail (Corporate license)


美國寵物醫療用品、服務市場:2014年、2019年預測 是由出版商The Freedonia Group在2010年08月所出版的。 這份英文市場調查報告書包含285 PAGES 價格從美金4800起跳。

簡介

美國寵物醫療用品、服務市場於2009年達到242億美金規模,預計2014年將可達到330億美金之成長。

本報告為,以美國寵物醫療用品、服務市場於1999年、2004年、2009年之需求數據,進行產品、服務、疾病症狀、動物種類於2014年、2019年之預測,並提供影響市場因素、主要企業市場佔有率及簡介等資訊,以下列摘要形式闡述。

簡介

第1章 實施概要

第2章 市場環境

  • 概要
  • 宏觀經濟展望
  • 消費者所得、支出趨勢
  • 人口統計趨勢
  • 寵物數統計趨勢
  • 寵物醫療服務供應商概要
  • 疾病症狀
  • 寵物醫療支出概要
  • 既有健康保健
  • 法規、環保議題
  • 全球寵物醫療市場

第3章 服務別市場

  • 概要
  • 獸醫
  • 獸醫外之寵物醫療
  • 寵物保險

第4章 產品別市場

  • 概要
  • 醫療藥品
  • 驅蟲劑
  • 配方食品
  • 營養補給食品
  • 疫苗
  • 診斷
  • 其他

第5章 症狀別市場

  • 概要
  • 皮膚
  • 心臟
  • 腸胃
  • 腎臟
  • 關節炎
  • 糖尿病
  • 其他

第6章 動物別市場

  • 概要
  • 其他

第7章 產業結構

  • 概要
  • 市場佔有率
    • Pfizer
    • Merial
    • Bayer
    • Novartis
    • Merck
    • 其他主要供應商
  • 產業重組
  • 競合策略
  • 競合協議
  • 行銷
  • 通路管道

企業簡介

目錄

Abstract

US pet health spending to reach $33 billion by 2014

Consumer spending on pet health products and services in the US is expected to reach $33 billion in 2014. Manufacturers' level pet health product demand is forecast to increase 5.8 percent per year to $5.5 billion that year. Gains will be driven by a growing pet population and, more significantly, the ongoing trend toward humanizing companion animals. Advances in veterinary technology will also drive pet health spending.

Preventive products to continue doing well

The perception of pets as family members has made pet health a traditionally "recession-resistant" industry. Although somewhat impacted by the recession that began in December 2007, spending on pet health has shown fairly steady growth over the last decade and will improve as pet owners are more able to afford expenses as the economy recovers. Preventive products, such as dietary supplements and certain parasiticides, have shown especially good growth recently, and will continue to do so. Among product types, pharmaceuticals overtook parasiticides as the largest demand segment in 2009.

Age-, weight-related conditions to increase demand

Increased spending on pet health has lengthened the expected lifespans of many companion animal species. Concurrently, incidences of age-related medical conditions (e.g., arthritis, cancer) have also grown. Weight-related conditions (e.g., diabetes, heart disease) will also lead to rising demand for products and services, as nearly 40 percent of pets are overweight or obese. In order to better afford these treatments, more owners will purchase pet insurance policies, with revenues expected to continue growing at double-digit annual rates. Spending to remain larger on dog health products Although cats represented the largest segment of the pet population, spending on health care products for dogs accounted for a disproportionate 68 percent of the total in 2009. Spending will remain larger on dog care products, as dogs' greater time spent outdoors increases their exposure to environmental hazards, and dogs are more susceptible to certain medical conditions, such as heart disease. However, research and development on more cat-specific health products will increase cats' share of the market going forward.

Study coverage

This new Freedonia industry study, Pet Health: Products & Services presents historical demand data (1999, 2004 and 2009) and forecasts for 2014 and 2019 by pet health service (e.g., veterinary care, non-veterinary pet care, pet insurance), product (e.g., pharmaceuticals, parasiticides, prescription food, dietary supplements, vaccines), condition (e.g., skin, heart, gastrointestinal, renal, arthritis) and animal. The study also considers market environment factors, evaluates company market share and profiles industry competitors.

Table of Contents

INTRODUCTION

I. EXECUTIVE SUMMARY

II. MARKET ENVIRONMENT

  • General
  • Macroeconomic Outlook
  • Consumer Income & Spending Trends
  • Demographic Trends
    • Population
    • Household Formation
  • Pet Demographic Trends
    • Cats
    • Dogs
    • Other Pets
    • Pet Health Service Provider Overview
    • Veterinary Practices & Employment
    • Non-Veterinary Pet Care
    • Pet & Pet Supply Stores
    • Pet Insurance
  • Medical Conditions
  • Pet Health Spending Overview
  • Nontraditional Health Care
  • Regulatory & Environmental Issues
    • Center for Veterinary Medicine
    • Animal & Plant Health Inspection Service
    • Environmental Protection Agency
    • Other Regulations
  • World Pet Health Care Market

III. SERVICES

  • General
  • Veterinary Care
    • Surgery
      • Growth Removal
      • Orthopedic
      • Gastrointestinal
      • Neutering/Spaying
      • Cosmetic Procedures
      • Other Surgical Procedures
    • Non-Surgical Procedures
  • Non-Veterinary Pet Care
  • Pet Insurance
    • Available Plans
    • Market Share

IV. PRODUCTS

  • General
  • Pharmaceuticals
    • Systemic Agents
      • Hormones & Insulin
      • Pain Control
      • Anti-Inflammatory Agents
      • Gastrointestinal Systemic Agents
      • Respiratory Systemic Agents
      • Cardiovascular Systemic Agents
      • Other Systemic Agents
    • Antibiotics
    • Other Pharmaceuticals
      • Anesthetic Agents
      • Euthanasia Agents
      • All Other Pharmaceuticals
  • Parasiticides
  • Flea & Tick
  • Heartworm
  • Other Parasiticides
  • Prescription Food
  • Dietary Supplements
  • Vaccines
  • Diagnostics
  • Other Pet Health Products

V. CONDITIONS

  • General
  • Skin Conditions
  • Heart Conditions
  • Gastrointestinal Conditions
  • Renal Conditions
  • Arthritis
  • Diabetes
  • Other Conditions
    • Respiratory Conditions
    • Cancer
    • All Other Conditions

VI. ANIMALS

  • General
  • Dogs
  • Cats
  • Other

VII. INDUSTRY STRUCTURE

  • General
  • Market Share
    • Pfizer
    • Merial
    • Bayer
    • Novartis
    • Merck
    • Other Major Suppliers
  • Industry Restructuring
  • Competitive Strategies
  • Cooperative Agreements
  • Marketing
  • Distribution Channels

COMPANY PROFILES

  • Abbott Laboratories
  • ADER Enterprises Incorporated
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Central Garden & Pet Company
  • Chomp, see Sergeant' s Pet Care Products
  • Church & Dwight Company Incorporated
  • Colgate-Palmolive Company
  • Eklin Medical Systems, see VCA Antech
  • Embrace Pet Insurance
  • Farnam, see Central Garden & Pet
  • Four Paws Products, see Central Garden & Pet
  • Hartville Group Incorporated
  • Hartz Mountain, see Sumitomo
  • Heska Corporation
  • Hill' s Pet Nutrition, see Colgate-Palmolive
  • IDEXX Laboratories Incorporated
  • Intervet/Schering-Plough Animal Health, see Merck
  • Mars Incorporated
  • Merck & Company Incorporated
  • Merial, see Sanofi-Aventis
  • Natura Pet Products, see Procter & Gamble
  • Nestle SA
  • Novartis AG
  • Nutri-Vet LLC
  • Nylabone Products, see Central Garden & Pet
  • PBI/Gordon Corporation
  • Pegasus Laboratories, see PBI/Gordon
  • Pet DRx Corporation
  • PetAg Incorporated
  • Pethealth Incorporated
  • Pfizer Incorporated
  • Procter & Gamble Company
  • PTZ, see Pethealth
  • Royal Canin, see Mars
  • Sanofi-Aventis
  • Schering-Plough, see Merck
  • Sergeant' s Pet Care Products Incorporated
  • Spectrum Brands Incorporated
  • Sumitomo Corporation
  • Summit VetPharm, see Sumitomo
  • VCA Antech Incorporated
  • Veterinary Pet Insurance Company
  • Virbac SA
  • Wellmark International, see Central Garden & Pet
  • Wyeth, see Pfizer
  • XLNT Veterinary Care, see Pet DRx
  • Other Companies Mentioned in Study

LIST OF TABLES

SECTION I -- EXECUTIVE SUMMARY

  • Summary Table

SECTION II -- MARKET ENVIRONMENT

  • 1 Macroeconomic Indicators
  • 2 Personal Consumption Expenditures
  • 3 Population
  • 4 Households & Pet Ownership
  • 5 Pet Population
  • 6 Pet Health Service Providers
  • 7 Selected Pet Medical Conditions
  • 8 Pet Health Retail Sales & Services Revenues

SECTION III -- SERVICES

  • 1 Pet Health Service Revenues by Type
  • 2 Veterinary Care Service Revenues by Type
  • 3 Surgery Revenues by Type
  • 4 Non-Surgical Revenues by Type
  • 5 Non-Veterinary Pet Care Revenues
  • 6 Pet Insurance Revenues

SECTION IV -- PRODUCTS

  • 1 Pet Health Product Demand by Type
  • 2 Pharmaceuticals Demand by Type & Animal
  • 3 Systemic Agents Demand by Type & Animal
  • 4 Antibiotics Demand by Type & Animal
  • 5 Other Pharmaceuticals Demand by Type & Animal
  • 6 Parasiticides Demand by Type & Animal
  • 7 Flea & Tick Treatment Demand by Type & Animal
  • 8 Heartworm Treatment Demand by Type & Animal
  • 9 Other Parasiticides Demand by Animal
  • 10 Prescription Pet Food Demand by Animal
  • 11 Dietary Supplement Demand by Type & Animal
  • 12 Vaccines Demand by Animal
  • 13 Diagnostics Demand by Animal
  • 14 Other Pet Health Product Demand by Product & Animal

SECTION V -- CONDITIONS

  • 1 Pet Health Product Demand by Condition
  • 2 Skin Conditions: Pet Health Product Demand by Type & Animal
  • 3 Heart Conditions: Pet Health Product Demand by Type & Animal
  • 4 Gastrointestinal Conditions: Pet Health Product Demand by Type & Animal
  • 5 Renal Conditions: Pet Health Product Demand by Type & Animal
  • 6 Arthritis: Pet Health Product Demand by Type & Animal
  • 7 Diabetes: Pet Health Product Demand by Type & Animal
  • 8 Other Conditions: Pet Health Product Demand by Type, Condition & Animal

SECTION VI -- ANIMALS

  • 1 Pet Health Product Demand by Animal
  • 2 Dog Health Product Demand by Type
  • 3 Cat Health Product Demand by Type
  • 4 Other Pet Health Product Demand by Type

SECTION VII -- INDUSTRY STRUCTURE

  • 1 Pet Health Product Sales by Company, 2009
  • 2 Selected Acquisitions & Divestitures
  • 3 Selected Cooperative Agreements

LIST OF CHARTS

SECTION II -- MARKET ENVIRONMENT

  • 1 World Pet Health Product & Service Demand, 2009

SECTION III -- SERVICES

  • 1 Pet Insurance Market Share by Company, 2009

SECTION IV -- PRODUCTS

  • 1 Pet Health Product Demand by Type, 2009

SECTION V -- CONDITIONS

  • 1 Pet Health Product Demand by Condition, 2009

SECTION VI -- ANIMALS

  • 1 Pet Health Product Demand by Animal, 2009

SECTION VII -- INDUSTRY STRUCTURE

  • 1 Pet Health Product Market Share by Company, 2009

Press Release

美國寵物醫療支出於2014年時將超過330億美元

2010年08月16日

Global Information, Inc.已開始銷售美國市場調查公司The Freedonia Group所發行的報告書「Pet Health: Products & Services (US industry forecasts for 2014 & 2019) (美國寵物醫療用品、服務市場:2014年、2019年預測)」

依據該報告,美國寵物醫療用品及服務的全部支出,預計以年率6.5%擴大,2014年時將達到331億美元。而且預計62%的家庭在預測期間內至少擁有一隻寵物,則2014年時該國的寵物數將超過2億隻以上。零售部門中預測消費者約花費117億美元在寵物醫療用品。此外,全部寵物用品的零售銷售額比預測的情況更佳,該市場顯示「對不景氣有強力的抵抗力」。預測此零售銷售額將從2009年的水準以年率5.2%擴大。另一方面,關於寵物醫療用品的需求,製造廠以年率5.8%上升,預估2014年將達到55億美元。

該書的要點

  • 預測獸醫醫療是來自接續人類醫療(器官移植術、透析療法及美容整形)技術的轉移
  • 預測寵物保險將成為急速成長的部門,到2014年為止將以年率17%增加
  • 預測加入保險的寵物數及保險收益比例,在2014年之前將倍增
  • 預測線上藥局及寵物用超市的市占率成長,將因成本刪減的傾向而繼續超過獸醫診療部門
  • 因製造商之營養補充品需求收益劇增,預計將促進預防醫療受重視

US PET HEALTH: PRODUCTS & SERVICES
(million dollars)
% Annual Growth
Item2004200920142004-20092009-2014
Pet Health Spending1762024205331006.66.5
Services1068015175214507.37.2
Retail69409030116505.45.2
      
Manufacturers Pet Health Products3144417055305.85.8

©2010 by The Freedonia Group, Inc.

Back to Top